| Literature DB >> 33864103 |
Emanuele Monda1, Adelaide Fusco1, Alessandro Della Corte1, Martina Caiazza1, Annapaola Cirillo1, Felice Gragnano1,2, Maria Pina Giugliano1, Rodolfo Citro3, Marta Rubino1, Augusto Esposito1, Arturo Cesaro1,2, Francesco Di Fraia1, Giuseppe Palmiero4, Marco Di Maio1, Marcellino Monda5, Paolo Calabrò1,2, Giulia Frisso6, Stefano Nistri7, Eduardo Bossone8, Simon C Body9, Maria Giovanna Russo1, Giuseppe Limongelli10,11.
Abstract
Patients with bicuspid aortic valve (BAV) have an increased risk of aortic dilation and aortic dissection or rupture. The impact of physical training on the natural course of aortopathy in BAV patients remains unclear. The aim of this study was to evaluate the impact of regular physical activity on aortic diameters in a consecutive cohort of paediatric patients with BAV. Consecutive paediatric BAV patients were evaluated and categorized into two groups: physically active and sedentary subjects. Only the subjects with a complete 2-year follow-up were included in the study. To evaluate the potential impact of physical activity on aortic size, aortic diameters were measured at the sinus of Valsalva and mid-ascending aorta using echocardiography. We defined aortic diameter progression the increase of aortic diameter ≥ 10% from baseline. Among 90 BAV patients (11.5 ± 3.4 years of age, 77% males), 53 (59%) were physically active subjects. Compared to sedentary, physically active subjects were not significantly more likely to have > 10% increase in sinus of Valsalva (13% vs. 8%, p-value = 0.45) or mid-ascending aorta diameter (9% vs. 13%, p-value = 0.55) at 2 years follow-up, both in subjects with sinus of Valsalva diameter progression (3.7 ± 1.0 mm vs. 3.5 ± 0.8 mm, p-value = 0.67) and in those with ascending aorta diameter progression (3.0 ± 0.8 mm vs. 3.2 ± 1.3 mm, p-value = 0.83). In our paediatric cohort of BAV patients, the prevalence and the degree of aortic diameter progression was not significantly different between physically active and sedentary subjects, suggesting that aortic dilation is unrelated to regular physical activity over a 2-year period.Entities:
Keywords: Aortopathy; Bicuspid aortic valve; Echocardiography; Exercise; Paediatrics
Mesh:
Year: 2021 PMID: 33864103 PMCID: PMC8192390 DOI: 10.1007/s00246-021-02591-4
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655
Fig. 1Distribution of bicuspid aortic valve morphologies in our cohort. Type 0, valves with no raphe; type 1, valves with one raphe; type 2, valves with two raphes
Clinical characteristics of the examined cohort
| Clinical features | Total population |
|---|---|
| Age at diagnosis, years | 4.1 ± 4.4 |
| Age at study enrolment, years | 11.6 ± 3.4 |
| Body surface area, m2 | 1.4 ± 0.4 |
| Males | 67 (76.7) |
| Diagnosis | |
| Incidental | 14 (15.5) |
| Cardiac murmur | 68 (75.5) |
| Symptomatology | 8 (8.9) |
| Physically active subjects | 53 (58.9) |
Data are presented in mean ± SD or n (%)
Clinical characteristics of the two groups
| Clinical features | Physically active subjects' group ( | Sedentary subject' group ( | |
|---|---|---|---|
| Age at diagnosis, years | 4.8 ± 4.7 | 3.2 ± 3.7 | 0.088 |
| Age at study enrolment, years | 13.2 ± 2.5 | 9.3 ± 3.0 | < 0.001* |
| Body surface area, m2 | 1.6 ± 0.3 | 1.3 ± 0.3 | < 0.001* |
| BAV morphology | 0.970 | ||
| Type 0 | 4 (7.5) | 3 (8.1) | 0.922 |
| Type 1 | 44 (83) | 30 (81.1) | 0.813 |
| Subtype R-L | 31 (58.5) | 21 (56.7) | 0.966 |
| Subtype R-NC | 13 (24.5) | 9 (24.3) | 0.966 |
| Type 2 | 5 (9.4) | 4 (10.8) | 0.830 |
| Aortic regurgitation | 28 (52.8) | 19 (51.3) | 0.890 |
| Mild | 24 (45.3) | 11 (29.7) | 0.136 |
| Moderate | 3 (5.7) | 5 (13.5) | 0.198 |
| Severe | 1 (1.9) | 3 (8.1) | 0.159 |
Sinuses of Valsalva diameter mm | 27.2 ± 4.3 | 23.8 ± 3.9 | < 0.001* |
| z score, median (IQR) | 0.7 (1.9) | 0.4 (1.6) | 0.253 |
Sinuses of Valsalva dilation, mild (≥ 2 and ≤ 4 severe (> 4 | 8 (15.1) | 5 (13.5) | 0.834 |
| 8 (15.1) | 4 (10.8) | 0.556 | |
| 0 (0) | 1 (2.7) | 0.229 | |
Ascending aorta diameter mm | 28.3 ± 5.1 | 25.6 ± 4.4 | 0.009* |
| z score, median (IQR) | 2.4 (2.5) | 2.8 (2.6) | 0.633 |
Ascending aorta dilation, mild (≥ 2 and ≤ 4 severe (> 4 | 33 (62.3) | 21 (56.7) | 0.600 |
| 20 (37.7) | 16 (43.2) | 0.600 | |
| 13 (24.5) | 5 (13.5) | 0.199 | |
| Sinus of Valsalva diameter progression > 10 mm | 7 (13.2) | 3 (8.1) | 0.449 |
| Ascending aorta diameter progression > 10 mm | 5 (9.4) | 5 (13.5) | 0.545 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
BAV bicuspid aortic valve
*p-values < 0.05 were considered statistically significant
Echocardiographic findings of study population at baseline and at 2 years follow-up
| Clinical features | Baseline | 2 years follow-up | |
|---|---|---|---|
| Physically active subjects' group | |||
| Age at study enrolment, years | 13.2 ± 2.5 | 15.2 ± 2.5 | < 0.001* |
Sinuses of Valsalva diameter mm | 27.2 ± 4.3 | 27.3 ± 4.5 | 0.863 |
| z score, median (IQR) | 0.7 (1.9) | 0.6 (1.9) | 0.212 |
Ascending aorta diameter mm | 28.3 ± 5.1 | 28.4 ± 5.3 | 0.733 |
| z score, median (IQR) | 2.4 (2.5) | 2.5 (2.7) | 0.354 |
| Sedentary subjects' group | |||
| Age at presentation, years | 9.3 ± 3.0 | 11.3 ± 3.0 | < 0.001* |
Sinuses of Valsalva diameter mm | 23.8 ± 3.9 | 24.5 ± 4.4 | < 0.001* |
| z score, median (IQR) | 0.4 (1.6) | 0.6 (1.3) | 0.174 |
Ascending aorta diameter mm | 25.6 ± 4.4 | 26.5 ± 4.7 | 0.007* |
| z score, median (IQR) | 2.8 (2.6) | 2.5 (2.2) | 0.251 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
Sinus of Valsalva and ascending aortic diameter changes from baseline in the two groups during the 2 years follow-up
| Clinical features | Physically active subjects' group ( | Sedentary subjects' group ( | |
|---|---|---|---|
| Sinuses of Valsalva diameter, changes from baseline (mm) | 0.1 ± 2.2 | 0.7 ± 1.2 | 0.098 |
| z score, median (IQR) | 0.0 (0.3) | 0.1 (0.3) | 0.104 |
Ascending aorta diameter, changes from baseline mm | 0.1 ± 2.0 | 0.9 ± 2.0 | 0.056 |
| z score, median (IQR) | 0.0 (0.6) | 0.0 (0.5) | 0.174 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
Sinus of Valsalva diameter changes from baseline in subjects with sinus of Valsalva diameter progression during the 2 years follow-up
| Clinical features | Physically active subjects' group ( | Sedentary subjects' group ( | |
|---|---|---|---|
Sinuses of Valsalva diameter, changes from baseline mm | 3.7 ± 1.0 | 3.5 ± 0.8 | 0.673 |
| z score, median (IQR) | 1.0 (0.2) | 1.0 (0.2) | 0.747 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
Ascending aorta diameter changes from baseline in subjects with ascending aorta diameter progression during the 2 years follow-up
| Clinical features | Physically active subjects' group ( | Sedentary subjects' group ( | |
|---|---|---|---|
Ascending aorta diameter, changes from baseline mm | 3.0 ± 0.8 | 3.2 ± 1.3 | 0.830 |
| z score, median (IQR) | 0.8 (0.6) | 0.8 (0.5) | 0.593 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
Sinus of Valsalva diameter changes from baseline in subjects with sinus of Valsalva dilation at baseline during the 2 years follow-up
| Clinical features | Physically active subjects' group ( | Sedentary subjects' group ( | |
|---|---|---|---|
Sinuses of Valsalva diameter, changes from baseline mm | 1.6 ± 1.6 | 0.0 ± 2.9 | 0.216 |
| z score, median (IQR) | 0.3 (0.9) | -0.1 (0.9) | 0.061 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
Ascending aorta diameter changes from baseline in subjects with ascending aorta dilation during the 2 years follow-up
| Clinical features | Physically active subjects' group ( | Sedentary subjects' group ( | |
|---|---|---|---|
Ascending aorta diameter, changes from baseline mm | 1.4 ± 1.6 | 1.4 ± 1.3 | 0.957 |
| z score, median (IQR) | 0.2 (0.6) | 0.3 (0.5) | 0.906 |
Data are presented in mean ± SD or n (%), unless otherwise indicated
*p-values < 0.05 were considered statistically significant
| Site | Principal investigator | |
|---|---|---|
| Brigham and Women’s Hospital | Simon C. Body | scbody@bu.edu |
| Laval | Yohan Bossé | Yohan.Bosse@criucpq.ulaval.ca |
| Mayo | Hector I. Michelena | michelena.hector@mayo.edu |
| Massachusetts General Hospital | Thoralf M. Sundt | tsundt@mgh.harvard.edu |
| Michigan | Bo Yang | boya@med.umich.edu |
| Oxford | Malenka Bissell | malenka.bissell@cardiov.ox.ac.uk |
| San Donato (Milan) | Francesca Pluchinotta | francesca.pluchinotta@grupposandonato.it |
| University of Texas, Houston | Dianna M. Milewicz | dianna.M.Milewicz@uth.tmc.edu |
| Tufts University | Gordon Huggins | ghuggins@tuftsmedicalcenter.org |
| Vall d’Hebron (Barcelona) | Arturo Evangelista | arturevangelistamasip@ gmail.com |
| Vanderbilt | Joshua C. Denny | josh.denny@vanderbilt.edu |